These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4281167)

  • 1. Comparative studies on the in vivo distribution pattern of dibromodulcitol and diepoxydulcitol.
    Pethes G
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1973; 79(1):49-59. PubMed ID: 4281167
    [No Abstract]   [Full Text] [Related]  

  • 2. The absorption and metabolism of dibromodulcitol in patients with advanced cancer.
    Belej MA; Troetel WM; Weiss AJ; Stambaugh JE; Manthei RW
    Clin Pharmacol Ther; 1972; 13(4):563-72. PubMed ID: 5042371
    [No Abstract]   [Full Text] [Related]  

  • 3. Incorporation of 3H-dibromodulcitol and 3H-dianhydrodulcitol into ascites tumor cells. Autoradiographic study.
    Kopper L; Lapis K; Institóris L
    Neoplasma; 1976; 23(1):47-52. PubMed ID: 1272473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of the differences of biological effects and distribution parameters of 1,6-dibromohexitols].
    Institóris L; Dzurillay E; Sebestyén JH; Jeney A; Pethes G
    Z Krebsforsch; 1971; 75(2):133-45. PubMed ID: 4256522
    [No Abstract]   [Full Text] [Related]  

  • 5. A preliminary Pharmacokinetic study of dianhydrogalactitol (NSC-132313) disposition in the dog.
    Kimura T; Sternson LA; Stella VJ; Higuchi T
    J Natl Cancer Inst; 1977 May; 58(5):1311-4. PubMed ID: 857026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathway of galactitol catabolism in Klebsiella pneumoniae: oxidation of L-galactitol-1-phosphate by a NAD-specific dehydrogenase.
    Markwell JP; Anderson RL
    Arch Biochem Biophys; 1981 Jul; 209(2):592-7. PubMed ID: 7027959
    [No Abstract]   [Full Text] [Related]  

  • 7. A mutant inducible for galactitol utilization in Escherichia coli K12.
    Delidakis CE; Jones-Mortimer MC; Kornberg HL
    J Gen Microbiol; 1982 Mar; 128(3):601-4. PubMed ID: 7042910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galactitol accumulation and irreversible lens opacities in galactosemic rats.
    Simard-Duquesne N; Dvornik D
    Invest Ophthalmol; 1973 Jan; 12(1):82-3. PubMed ID: 4691951
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the distribution of dianhydrogalactitol into the central nervous system of the rat.
    Munger D; Sternson LA; Patton TF
    Cancer Treat Rep; 1978 Mar; 62(3):409-12. PubMed ID: 647698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of mutations affecting the dissmilation of galactitol (dulcitol) in Escherichia coli K 12.
    Lengeler J
    Mol Gen Genet; 1977 Mar; 152(1):83-91. PubMed ID: 325390
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of polyol pathway activity in diabetic and galactosemic rats by the aldose reductase inhibitor CP-45,634.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Adv Exp Med Biol; 1979; 119():347-56. PubMed ID: 115231
    [No Abstract]   [Full Text] [Related]  

  • 12. Dietary restriction of maternal lactose intake does not prevent accumulation of galactitol in the amniotic fluid of fetuses affected with galactosaemia.
    Jakobs C; Kleijer WJ; Bakker HD; van Gennip AH; Przyrembel H; Niermeijer MF
    Prenat Diagn; 1988 Nov; 8(9):641-5. PubMed ID: 3211853
    [No Abstract]   [Full Text] [Related]  

  • 13. An alternative route for D-galactose catabolism shared with that for dulcitol degradation route in mycobacteria.
    Szumiło T
    FEBS Lett; 1981 Feb; 124(2):270-2. PubMed ID: 7227532
    [No Abstract]   [Full Text] [Related]  

  • 14. Hexitol production by canine retinal microvessels.
    Kern TS; Engerman RL
    Invest Ophthalmol Vis Sci; 1985 Mar; 26(3):382-4. PubMed ID: 3972519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of dibromodulcitol (NSC 104800) on intravenously induced cytemia of rats.
    Németh L
    Neoplasma; 1971; 18(5):533-7. PubMed ID: 5119525
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pharmacology of dibromohexitols.
    Eckhardt S
    Haematologica; 1972 Apr; 57(11):722-31. PubMed ID: 4200307
    [No Abstract]   [Full Text] [Related]  

  • 17. Uptake of labeled dianhydrogalactitol into human gliomas and nervous tissue.
    Eckhardt S; Csetényi J; Horváth IP; Kerpel-Fronius S; Számel I; Institóris L; Szlovik F; Pásztor E; Afra D
    Cancer Treat Rep; 1977 Aug; 61(5):841-7. PubMed ID: 890693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experiences with dibromodulcitol (NSC-104800) in solid tumors.
    Phillips RW; Brook J
    Cancer Chemother Rep; 1971 Dec; 55(5):567-73. PubMed ID: 4946081
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential antitumor agents. Some 1,6-disubstituted galactitol and mannitol derivatives.
    Acton EM; Keyanpour-Rad M; Christensen JE; Tong HH; Kwok RP; Goodman L
    Carbohydr Res; 1972 May; 22(2):477-86. PubMed ID: 5047748
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I study of dibromodulcitol (NSC-104800).
    Andrews NC; Weiss AJ; Ansfield FJ; Rochlin DB; Mason JH
    Cancer Chemother Rep; 1971 Feb; 55(1):61-5. PubMed ID: 5121653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.